Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001012990 | SCV001173520 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-09-18 | criteria provided, single submitter | clinical testing | The c.1746_1751delGGGAGC variant (also known as p.G583_A584del) is located in coding exon 13 of the POLD1 gene. This variant results from an in-frame GGGAGC deletion at nucleotide positions 1746 to 1751. This results in the in-frame deletion of two residues at codon 583 to 584. This amino acid region is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |